Article
Treating leukemia at the risk of inducing severe anemia.
Experimental hematology - 1 May 2016
Chen Wendy S, Zhu Helen He, Feng Gen-Sheng
Abstract excerpt
Anemia is a frequently observed adverse effect in cancer patients who receive chemotherapy or drugs designed to block specific oncogenic signaling pathways, although the underlying mechanisms are poorly understood. An article first published online (Zhu HH, Luo X, Zhang K, et al. Proc Natl Acad Sci USA 2015;112:13342-13347) presented data indicating that cell type-specific pathway cross-talk is likely an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
